Related references
Note: Only part of the references are listed.Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Complicated Disease and Response to Initial Therapy Predicts Early Surgery in Paediatric Crohn's Disease: Results From the Porto Group GROWTH Study
Arie Levine et al.
JOURNAL OF CROHNS & COLITIS (2020)
Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patients
Constance Chapuis-Biron et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease
Aleksejs Sazonovs et al.
GASTROENTEROLOGY (2020)
OP38 Top-down infliximab superior to step-up in children with Moderate-to-Severe Crohn’s disease: A multicentre randomised controlled trial
M Jongsma et al.
Journal of Crohns & Colitis (2020)
Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Infliximab in Pediatric Inflammatory Bowel Disease: A Systematic Review and Revised Dosing Considerations
Dwight A. Winter et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2020)
ASPEN Consensus Recommendations for Refeeding Syndrome
Joshua S. V. da Silva et al.
NUTRITION IN CLINICAL PRACTICE (2020)
Long-Term Efficacy of Anti-Tumor Necrosis Factor Agents in Pediatric Luminal Crohn's Disease: A Systematic Review of Real-World Evidence Studies
Hanna van Rheenen et al.
PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION (2020)
Rapid Response to Vedolizumab Therapy in Biologic-Naive Patients With Inflammatory Bowel Diseases
Brian G. Feagan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease
Britt Christensen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Azithromycin and metronidazole versus metronidazole-based therapy for the induction of remission in mild to moderate paediatric Crohn's disease : a randomised controlled trial
Arie Levine et al.
GUT (2019)
Higher Postinduction Infliximab Serum Trough Levels Are Associated With Healing of Fistulizing Perianal Crohn's Disease in Children
Wael El-Matary et al.
INFLAMMATORY BOWEL DISEASES (2019)
Folate Supplementation for Methotrexate Therapy in Patients With Rheumatoid Arthritis A Systematic Review
Lijun Liu et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2019)
Comparative Efficacy of Anti-TNF Therapies For The Prevention of Postoperative Recurrence of Crohn's Disease A Systematic Review and Network Meta-Analysis of Prospective Trials
Ziad Bakouny et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2019)
Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases
Joseph Meserve et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis
Jean-Frederic Colombel et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease-The Israeli real world experience
Uri Kopylov et al.
DIGESTIVE AND LIVER DISEASE (2019)
Vedolizumab Drug Level Correlation With Clinical Remission, Biomarker Normalization, and Mucosal Healing in Inflammatory Bowel Disease
Badr Al-Bawardy et al.
INFLAMMATORY BOWEL DISEASES (2019)
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
Christian Maaser et al.
JOURNAL OF CROHNS & COLITIS (2019)
Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases
Konstantinos Papamichael et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases
Andres J. Yarur et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease
Gareth J. Walker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Proactive Therapeutic Drug Monitoring of Adalimumab Is Associated With Better Long-term Outcomes Compared With Standard of Care in Patients With Inflammatory Bowel Disease
Konstantinos Papamichael et al.
JOURNAL OF CROHNS & COLITIS (2019)
Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort
N. Plevris et al.
JOURNAL OF CROHNS & COLITIS (2019)
Development of Infliximab Target Concentrations During Induction in Pediatric Crohn Disease Patients
Kathryn Clarkston et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2019)
Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn's disease patients
Alice Jane Foster et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Vedolizumab trough level monitoring in inflammatory bowel disease: a state-of-the-art overview
Lieven Pouillon et al.
BMC MEDICINE (2019)
Real World Experience With Ustekinumab in Children and Young Adults at a Tertiary Care Pediatric Inflammatory Bowel Disease Center
Judy R. Dayan et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2019)
The reduction of faecal calprotectin during exclusive enteral nutrition is lost rapidly after food re-introduction
Michael Logan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease
Raffaella Franca et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2019)
Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring
Amit Assa et al.
GASTROENTEROLOGY (2019)
Time-to-reach Target Calprotectin Level in Newly Diagnosed Patients With Inflammatory Bowel Disease
Sjoukje-Marije Haisma et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2019)
Head-to-head comparison of three stool calprotectin tests for home use
Sjoukje-Marije Haisma et al.
PLOS ONE (2019)
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
Nicholas A. Kennedy et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease
David R. Mack et al.
GASTROENTEROLOGY (2019)
Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial
Arie Levine et al.
GASTROENTEROLOGY (2019)
The effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in paediatric patients with Crohn's disease: a post hoc analysis
Jeffrey S. Hyams et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition
Vaios Svolos et al.
GASTROENTEROLOGY (2019)
Variation in Care in the Management of Children With Crohn's Disease: Data From a Multicenter Inception Cohort Study
Chenthan Krishnakumar et al.
INFLAMMATORY BOWEL DISEASES (2019)
Management of Paediatric Patients With Medically Refractory Crohn's Disease Using Ustekinumab: A Multi-Centred Cohort Study
Mallory Chavannes et al.
JOURNAL OF CROHNS & COLITIS (2019)
Mucosal Healing and Bacterial Composition in Response to Enteral Nutrition Vs Steroid-based Induction Therapy-A Randomised Prospective Clinical Trial in Children With Crohn's Disease
Benedicte Pigneur et al.
JOURNAL OF CROHNS & COLITIS (2019)
Capsule Endoscopy, Magnetic Resonance Enterography, and Small Bowel Ultrasound for Evaluation of Postoperative Recurrence in Crohn's Disease: Systematic Review and Meta-Analysis
Diana E. Yung et al.
INFLAMMATORY BOWEL DISEASES (2018)
Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review
Mahboube Ganji-Arjenaki et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Differences in Outcomes Over Time With Exclusive Enteral Nutrition Compared With Steroids in Children With Mild to Moderate Crohn's Disease: Results From the GROWTH CD Study
Noa Cohen-Dolev et al.
JOURNAL OF CROHNS & COLITIS (2018)
Vedolizumab in IBD-Lessons From Real-world Experience; A Systematic Review and Pooled Analysis
Tal Engel et al.
JOURNAL OF CROHNS & COLITIS (2018)
High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab - a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO)
Tero Ylisaukko-oja et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2018)
Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN
M. E. Joosse et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study)
A. B. Friedman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability
Andrea Padoan et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Efficacy of Medical Therapies for Fistulizing Crohn's Disease: Systematic Review and Meta-analysis
Matthew J. Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases
Erwin Dreesen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Associations Among Mucosal and Transmural Healing and Fecal Level of Calprotectin in Children With Crohn's Disease
Inbar Weinstein-Nakar et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Infliximab trough levels and persistent vs transient antibodies measured early after induction predict long-term clinical remission in patients with inflammatory bowel disease
Giorgia Bodini et al.
DIGESTIVE AND LIVER DISEASE (2018)
A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study
Marco Vincenzo Lenti et al.
DIGESTIVE AND LIVER DISEASE (2018)
Long-Term Outcome of Infliximab Optimization for Overcoming Immunogenicity in Patients with Inflammatory Bowel Disease
Konstantinos Papamichael et al.
DIGESTIVE DISEASES AND SCIENCES (2018)
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease
Geert D'Haens et al.
GASTROENTEROLOGY (2018)
Methotrexate for the Treatment of Pediatric Crohn's Disease: A Systematic Review and Meta-analysis
Ruben J. Colman et al.
INFLAMMATORY BOWEL DISEASES (2018)
Association Between Serum Infliximab Trough Concentrations During Maintenance Therapy and Biochemical, Endoscopic, and Histologic Remission in Crohn's Disease
Konstantinos Papamichael et al.
INFLAMMATORY BOWEL DISEASES (2018)
Effectiveness and Safety of Vedolizumab in Anti-TNF-Naive Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study
Uri Kopylov et al.
INFLAMMATORY BOWEL DISEASES (2018)
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease
Eugenia Shmidt et al.
INFLAMMATORY BOWEL DISEASES (2018)
Therapeutic Drug Monitoring Guides the Management of Crohn's Patients with Secondary Loss of Response to Adalimumab
Sophie Restellini et al.
INFLAMMATORY BOWEL DISEASES (2018)
Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety
Britt Christensen et al.
INFLAMMATORY BOWEL DISEASES (2018)
Efficacy of Adalimumab for Treatment of Perianal Fistula in Children with Moderately to Severely Active Crohn's Disease: Results from IMAgINE 1 and IMAgINE 2
Frank M. Ruemmele et al.
JOURNAL OF CROHNS & COLITIS (2018)
Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
Stefan Schreiber et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Long-term Outcomes of Infliximab Use for Pediatric Crohn Disease: A Canadian Multicenter Clinical Practice Experience
Jennifer C. deBruyn et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2018)
European Society of Paediatric Radiology Abdominal Imaging Task Force recommendations in paediatric uroradiology, part X: how to perform paediatric gastrointestinal ultrasonography, use gadolinium as a contrast agent in children, follow up paediatric testicular microlithiasis, and an update on paediatric contrast-enhanced ultrasound
Michael Riccabona et al.
PEDIATRIC RADIOLOGY (2018)
Success and safety of high infliximab trough levels in inflammatory bowel disease
David Drobne et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2018)
Vedolizumab for inflammatory bowel disease: from randomized controlled trials to real-life evidence
Maria Lia Scribano
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Impact of Epstein-Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease
Ruth de Francisco et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Real-world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel disease
Paulo G. Kotze et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Endoscopy in Pediatric Inflammatory Bowel Disease: A Position Paper on Behalf of the Porto IBD Group of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition
Salvatore Oliva et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2018)
Protocol for Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Haiming Fang et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry
Maria Chaparro et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Response to treatment is more important than disease severity at diagnosis for prediction of early relapse in new-onset paediatric Crohn's disease
Tomer Ziv-Baran et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn's disease: systematic review and meta-analysis
Yuen Sau Tham et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2018)
Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents
Silvia Ghione et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Nutritional support in paediatric Crohn's disease: outcome at 12 months
J. Gavin et al.
ACTA PAEDIATRICA (2018)
The safety of vedolizumab for ulcerative colitis and Crohn's disease
Jean-Frederic Colombel et al.
GUT (2017)
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management
Fernando Gomollon et al.
JOURNAL OF CROHNS & COLITIS (2017)
Cost-effectiveness of drug monitoring of anti-TNF therapy in inflammatory bowel disease and rheumatoid arthritis: a systematic review
Laura Martelli et al.
JOURNAL OF GASTROENTEROLOGY (2017)
FISTULA HEALING IN PIVOTAL STUDIES OF USTEKINUMAB IN CROHN'S DISEASE
Bruce E. Sands et al.
GASTROENTEROLOGY (2017)
Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease
Jeffrey S. Hyams et al.
GASTROENTEROLOGY (2017)
Comparison of Health Care Utilization and Costs Between Patients with Perianal Fistulizing Crohn's Disease Treated with Biologics with or Without Previous Seton Placement
David A. Schwartz et al.
INFLAMMATORY BOWEL DISEASES (2017)
Risk for Overall Infection with Anti-TNF and Anti-integrin Agents Used in IBD: A Systematic Review and Meta-analysis
Eric D. Shah et al.
INFLAMMATORY BOWEL DISEASES (2017)
Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease: A Systematic Review and Practical Guide
Anke Heida et al.
INFLAMMATORY BOWEL DISEASES (2017)
Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease
Christian P. Selinger et al.
INFLAMMATORY BOWEL DISEASES (2017)
Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease
Orlaith B. Kelly et al.
INFLAMMATORY BOWEL DISEASES (2017)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naive to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy
Bruce E. Sands et al.
INFLAMMATORY BOWEL DISEASES (2017)
Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease
Magali Lemaitre et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Vedolizumab Induces Long-term Mucosal Healing in Patients With Crohn's Disease and Ulcerative Colitis
Maja Noman et al.
JOURNAL OF CROHNS & COLITIS (2017)
Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN
Oren Ledder et al.
JOURNAL OF CROHNS & COLITIS (2017)
Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease
Maria Rosario et al.
JOURNAL OF CROHNS & COLITIS (2017)
Clinical Use of Infliximab Trough Levels and Antibodies to Infliximab in Pediatric Patients With Inflammatory Bowel Disease
Laura Merras-Salmio et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2017)
Which PCDAI Version Best Reflects Intestinal Inflammation in Pediatric Crohn Disease?
Dan Turner et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2017)
Surgical Management of Crohn Disease in Children: Guidelines From the Paediatric IBD Porto Group of ESPGHAN
Jorge Amil-Dias et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2017)
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
Jean-Frederic Colombel et al.
LANCET (2017)
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study
Subra Kugathasan et al.
LANCET (2017)
Paediatric magnetic resonance enteroclysis under general anaesthesia - initial experience
Sophie Sadigh et al.
PEDIATRIC RADIOLOGY (2017)
Patient perceptions of glucocorticoid side effects: a cross-sectional survey of users in an online health community
Ruth Costello et al.
BMJ OPEN (2017)
Diagnostic Performance of Magnetic Resonance Enterography for Detection of Active Inflammation in Children and Adolescents With Inflammatory Bowel Disease A Systematic Review and Diagnostic Meta-analysis
Hee Mang Yoon et al.
JAMA PEDIATRICS (2017)
Maintenance of Remission with Partial Enteral Nutrition Therapy in Pediatric Crohn’s Disease: A Retrospective Study
Jacqueline M. Schulman et al.
Canadian Journal of Gastroenterology and Hepatology (2017)
Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centres
Mark A. Samaan et al.
FRONTLINE GASTROENTEROLOGY (2017)
Significance of measurement of serum trough level and anti-drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trial
H. Nakase et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Therapeutic drug monitoring was helpful in guiding the decision-making process for children receiving infliximab for inflammatory bowel disease
Vini Deora et al.
ACTA PAEDIATRICA (2017)
Systematic review with meta-analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease
A. Swaminath et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Improved Long-term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab
Konstantinos Papamichael et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Association Between Ustekinumab Trough Concentrations and Clinical, Biomarker, and Endoscopic Outcomes in Patients With Crohn's Disease
Robert Battat et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide
Marzia Lazzerini et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial
X. Roblin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
Livia Biancone et al.
DIGESTIVE AND LIVER DISEASE (2017)
Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials
A. Cholapranee et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn's Disease Patients Stratified by Age
Vijay Yajnik et al.
ADVANCES IN THERAPY (2017)
Dietary treatment of Crohn's disease: perceptions of families with children treated by exclusive enteral nutrition, a questionnaire survey
Vaios Svolos et al.
BMC GASTROENTEROLOGY (2017)
Methotrexate for the Management of Crohn's Disease in Children
Lisa A. Scherkenbach et al.
ANNALS OF PHARMACOTHERAPY (2016)
Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases-A Prospective Study on Incidence and Severity
Niels Teich et al.
JOURNAL OF CROHNS & COLITIS (2016)
Vedolizumab Effectiveness and Safety Over the First Year of Use in an IBD Clinical Practice
Emily E. Vivio et al.
JOURNAL OF CROHNS & COLITIS (2016)
Vedolizumab induction therapy for inflammatory bowel disease in clinical practice - a nationwide consecutive German cohort study
D. C. Baumgart et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Treatment of perianal fistula in Crohn's disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment
E. J. de Groof et al.
COLORECTAL DISEASE (2016)
Fecal calprotectin for the prediction of small-bowel Crohn's disease by capsule endoscopy: a systematic review and meta-analysis
Uri Kopylov et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2016)
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection
Miguel Regueiro et al.
GASTROENTEROLOGY (2016)
Incidence of Bowel Surgery and Associated Risk Factors in Pediatric-Onset Crohn's Disease
Firas Rinawi et al.
INFLAMMATORY BOWEL DISEASES (2016)
Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel Disease
Namita Singh et al.
INFLAMMATORY BOWEL DISEASES (2016)
Vedolizumab Therapy in Severe Pediatric Inflammatory Bowel Disease
Maire A. Conrad et al.
INFLAMMATORY BOWEL DISEASES (2016)
Bowel Ultrasonography in the Management of Crohn's Disease. A Review with Recommendations of an International Panel of Experts
Emma Calabrese et al.
INFLAMMATORY BOWEL DISEASES (2016)
Adalimumab Monotherapy and a Combination with Azathioprine for Crohn's Disease: A Prospective, Randomized Trial
Takayuki Matsumoto et al.
JOURNAL OF CROHNS & COLITIS (2016)
Mucosal Healing in Paediatric Patients with Moderate-to-Severe Luminal Crohn's Disease Under Combined Immunosuppression: Escalation versus Early Treatment
Ben Kang et al.
JOURNAL OF CROHNS & COLITIS (2016)
Higher Adalimumab Drug Levels are Associated with Mucosal Healing in Patients with Crohn's Disease
E. Zittan et al.
JOURNAL OF CROHNS & COLITIS (2016)
Addition of Histology to the Paris Classification of Pediatric Crohn Disease Alters Classification of Disease Location
Melissa A. Fernandes et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2016)
Infliximab Dosing Strategies and Predicted Trough Exposure in Children With Crohn Disease
Adam Frymoyer et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2016)
Fecal calprotectin in the prediction of postoperative recurrence of Crohn's disease in children and adolescents
Maria Hukkinen et al.
JOURNAL OF PEDIATRIC SURGERY (2016)
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
B. G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn's disease
Giorgia Bodini et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2016)
Therapeutic Efficacy of Oral Enteral Nutrition in Pediatric Crohn's Disease: A Single Center Non-Comparative Retrospective Study
Hyun Jin Kim et al.
YONSEI MEDICAL JOURNAL (2016)
Top-down Infliximab Study in Kids with Crohn's disease (TISKids): an international multicentre randomised controlled trial
M. A. Cozijnsen et al.
BMJ OPEN GASTROENTEROLOGY (2016)
Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysis
P. De Cruz et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Systematic review: thalidomide and thalidomide analogues for treatment of inflammatory bowel disease
C. Yang et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Systematic review and meta-analysis: opportunistic infections and malignancies during treatment with anti-integrin antibodies in inflammatory bowel disease
P. Luthra et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
L. Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn's Disease
Victoria Grossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti-Tumor Necrosis Factor Therapy for Crohn's Disease: A Meta-analysis of Placebo-controlled Trials
Jennifer L. Jones et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Concentrations of 6-Thioguanine Nucleotide Correlate With Trough Levels of Infliximab in Patients With Inflammatory Bowel Disease on Combination Therapy
Andres J. Yarur et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease
Guillaume Bouguen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Azathioprine and 6-Mercaptopurine: A Meta-analysis
David S. Kotlyar et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease
Marieke J. H. Coenen et al.
GASTROENTEROLOGY (2015)
Magnetic resonance enterography, small-intestine contrast US, and capsule endoscopy to evaluate the small bowel in pediatric Crohn's disease: a prospective, blinded, comparison study
Marina Aloi et al.
GASTROINTESTINAL ENDOSCOPY (2015)
Perioperative Corticosteroid Management for Patients with Inflammatory Bowel Disease
Caitlin W. Hicks et al.
INFLAMMATORY BOWEL DISEASES (2015)
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
Vito Annese et al.
JOURNAL OF CROHNS & COLITIS (2015)
Methotrexate for Maintaining Remission in Paediatric Crohn's Patients with Prior Failure or Intolerance to Thiopurines: A Multicenter Cohort Study
Sjoukje-Marije Haisma et al.
JOURNAL OF CROHNS & COLITIS (2015)
Monotherapy With Infliximab Versus Combination Therapy in the Maintenance of Clinical Remission in Children With Moderate to Severe Crohn Disease
Jaroslaw Kierkus et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2015)
Infliximab Top-Down Strategy is Superior to Step-Up in Maintaining Long-Term Remission in the Treatment of Pediatric Crohn Disease
Yoo Min Lee et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2015)
Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: Results of the randomized phase 3 CADMUS study
Ian Landells et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Crohn's disease management after intestinal resection: a randomised trial
Peter De Cruz et al.
LANCET (2015)
Methotrexate is an efficient therapeutic alternative in children with thiopurine-resistant Crohn's disease
Iva Hojsak et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2015)
The association of infliximab trough levels with disease activity in pediatric inflammatory bowel disease
Daniel R. Hoekman et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2015)
Specialized enteral nutrition therapy in Crohn's disease patients on maintenance infliximab therapy: a meta-analysis
Douglas L. Nguyen et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2015)
Systematic review with meta-analysis: magnetic resonance enterography signs for the detection of inflammation and intestinal damage in Crohn's disease
P. C. Church et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Efficacy of oral methotrexate in paediatric Crohn's disease: a multicentre propensity score study
Dan Turner et al.
GUT (2015)
Development of an Algorithm Incorporating Pharmacokinetics of Adalimumab in Inflammatory Bowel Diseases
Xavier Roblin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
A retrospective study showing maintenance treatment options for paediatric CD in the first year following diagnosis after induction of remission with EEN: supplemental enteral nutrition is better than nothing!
Hazel Duncan et al.
BMC GASTROENTEROLOGY (2014)
Screening for adrenal suppression in children with inflammatory bowel disease discontinuing glucocorticoid therapy
Marianne Sidoroff et al.
BMC GASTROENTEROLOGY (2014)
Effects of Vedolizumab Induction Therapy for Patients With Crohn's Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
Bruce E. Sands et al.
GASTROENTEROLOGY (2014)
Methotrexate in Combination With Infliximab Is No More Effective Than Infliximab Alone in Patients With Crohn's Disease
Brian G. Feagan et al.
GASTROENTEROLOGY (2014)
Increased Effectiveness of Early Therapy With Anti-Tumor Necrosis Factor-α vs an Immunomodulator in Children With Crohn's Disease
Thomas D. Walters et al.
GASTROENTEROLOGY (2014)
Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial
Laurent Peyrin-Biroulet et al.
GUT (2014)
Hepatotoxicity Caused by Methotrexate Therapy in Children with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Pamela L. Valentino et al.
INFLAMMATORY BOWEL DISEASES (2014)
Comparison of Outcomes Parameters for Induction of Remission in New Onset Pediatric Crohn's Disease: Evaluation of the Porto IBD Group Growth Relapse and Outcomes with Therapy (GROWTH CD) Study
Arie Levine et al.
INFLAMMATORY BOWEL DISEASES (2014)
Retrospective Cohort Study of Methotrexate Use in the Treatment of Pediatric Crohn's Disease
Whitney Sunseri et al.
INFLAMMATORY BOWEL DISEASES (2014)
Infliximab Maintains Durable Response and Facilitates Catch-up Growth in Luminal Pediatric Crohn's Disease
Peter C. Church et al.
INFLAMMATORY BOWEL DISEASES (2014)
Usefulness of abdominal ultrasonography in the analysis of endoscopic activity in patients with Crohn's disease: Changes following treatment with immunomodulators and/or anti-TNF antibodies
Nadia Moreno et al.
JOURNAL OF CROHNS & COLITIS (2014)
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
F. M. Ruemmele et al.
JOURNAL OF CROHNS & COLITIS (2014)
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
J. F. Rahier et al.
JOURNAL OF CROHNS & COLITIS (2014)
ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents
Arie Levine et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2014)
A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia
Suk-Kyun Yang et al.
NATURE GENETICS (2014)
Fecal calprotectin in healthy children
Tonje Oord et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2014)
The long-term outcome of anti-tumor necrosis factor-α therapy related to fecal calprotectin values during induction therapy in pediatric inflammatory bowel disease
Kaija-Leena Kolho et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2014)
Systematic review: MRI enterography for assessment of small bowel involvement in paediatric Crohn's disease
E. Giles et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Validation of Endoscopic Activity Scores in Patients With Crohn's Disease Based on a Post Hoc Analysis of Data From SONIC
Marc Ferrante et al.
GASTROENTEROLOGY (2013)
Safety and Effectiveness of Long-term Allopurinol-Thiopurine Maintenance Treatment in Inflammatory Bowel Disease
Frank Hoentjen et al.
INFLAMMATORY BOWEL DISEASES (2013)
Effect of Thalidomide on Clinical Remission in Children and Adolescents With Refractory Crohn Disease A Randomized Clinical Trial
Marzia Lazzerini et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
MR Enterography in Pediatric Inflammatory Bowel Disease: Retrospective Assessment of Patient Tolerance, Image Quality, and Initial Performance Estimates
Imad Absah et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2012)
Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease
Hiroyuki Hanai et al.
DIGESTIVE AND LIVER DISEASE (2012)
Safety and Efficacy of Adalimumab for Moderate to Severe Crohn's Disease in Children
Jeffrey S. Hyams et al.
GASTROENTEROLOGY (2012)
Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions
Dan Turner et al.
INFLAMMATORY BOWEL DISEASES (2012)
Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control
Patrick F. van Rheenen
INFLAMMATORY BOWEL DISEASES (2012)
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The efficacy of exclusive nutritional therapy in paediatric Crohn's disease, comparing fractionated oral vs. continuous enteral feeding
A. Rubio et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Khurram J. Khan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease
David S. Kotlyar et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn's disease in children: REACH open-label extension
Jeffrey Hyams et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Tolerance and Efficacy of Azathioprine in Pediatric Crohn's Disease
Laura Riello et al.
INFLAMMATORY BOWEL DISEASES (2011)
Methotrexate in the Treatment of Inflammatory Bowel Disease: An 8-Year Retrospective Study in a Canadian Pediatric IBD Center
Stephanie Willot et al.
INFLAMMATORY BOWEL DISEASES (2011)
Short-course Ondansetron for the Prevention of Methotrexate-induced Nausea in Children With Crohn Disease
Anna Kempinska et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2011)
A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study
William G. Newman et al.
PHARMACOGENOMICS (2011)
Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels
Anssi Hamalainen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Endoscopic Ultrasound to Guide the Combined Medical and Surgical Management of Pediatric Perianal Crohn's Disease
Michael J. Rosen et al.
INFLAMMATORY BOWEL DISEASES (2010)
A prospective evaluation of the impact of allopurinol in pediatric and adult IBD patients with preferential metabolism of 6-mercaptopurine to 6-methylmercaptopurine
Mark E. Gerich et al.
JOURNAL OF CROHNS & COLITIS (2010)
A Single-center Experience With Methotrexate After Thiopurine Therapy in Pediatric Crohn Disease
Brendan Boyle et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2010)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection
Miguel Regueiro et al.
GASTROENTEROLOGY (2009)
Comparison of Two Dosing Methods for Induction of Response and Remission with Oral Budesonide in Active Pediatric Crohn's Disease: A Randomized Placebo-Controlled Trial
Arie Levine et al.
INFLAMMATORY BOWEL DISEASES (2009)
Infliximab Therapy in Children With Concurrent Perianal Crohn Disease: Observations From REACH
Wallace Crandall et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2009)
Methotrexate Treatment in Pediatric Crohn Disease Patients Intolerant or Resistant to Purine Analogues
B. Weiss et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2009)
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
Laurent Beaugerie et al.
LANCET (2009)
Increased Immune Reactivity Predicts Aggressive Complicating Crohn's Disease in Children
Marla C. Dubinsky et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease
William J. Sandborn et al.
GASTROENTEROLOGY (2008)
Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a Randomized trial
Gert Van Assche et al.
GASTROENTEROLOGY (2008)
Effect of early immunomodulator use in moderate to severe pediatric Crohn disease
Jaya Punati et al.
INFLAMMATORY BOWEL DISEASES (2008)
Fecal Calprotectin, Lactoferrin, and Endoscopic Disease Activity in Monitoring Anti-TNF-alpha Therapy for Crohn's Disease
Taina Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal cytokines during remission in patients with Crohn's disease: A prospective study
Takayuki Yamamoto et al.
INFLAMMATORY BOWEL DISEASES (2007)
Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease
Dan Turner et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Role of methotrexate in the management of Crohn disease
Madhur Ravikumara et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2007)
Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children
Jeffrey Hyams et al.
GASTROENTEROLOGY (2007)
Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: a prospective, non-randomized, parallel, controlled study
T. Yamamoto et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Efficacy of methotrexate in pediatric Crohn's disease:: A French multicenter study
S. Uhlen et al.
INFLAMMATORY BOWEL DISEASES (2006)
Effectiveness of an 'half elemental diet' as maintenance therapy for Crohn's disease: a randomized-controlled trial
S. Takagi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center
Sanjoy Banerjee et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2006)
Azathioprine maintains first remission in newly diagnosed pediatric Crohn's disease
Gerald J. Jaspers et al.
INFLAMMATORY BOWEL DISEASES (2006)
Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: A randomized controlled open-label trial
Osvaldo Borrelli et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Risk factors for initial surgery in pediatric patients with Crohn's disease
N Gupta et al.
GASTROENTEROLOGY (2006)
Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients
DK Amre et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Effect of systemic corticosteroid therapy on risk for intra-abdominal or pelvic abscess in non-operated Crohn's disease
A Agrawal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Thiopurine methyltransferase enzyme activity determination before treatment of inflammatory bowel disease with azathioprine: Effect on cost and adverse events
FA Sayani et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Budesonide versus prednisolone for the treatment of active Crohn's disease in children: a randomized, double-blind, controlled, multicentre trial
JC Escher
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2004)
Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study
S Ardizzone et al.
DIGESTIVE AND LIVER DISEASE (2003)
Age-dependent variations in fecal calprotectin concentrations in children
J Rugtveit et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2002)
A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease
J Markowitz et al.
GASTROENTEROLOGY (2000)
Share Paper
